Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir

NCT02511431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Lonafarnib
DRUG: Ritonavir
OTHER: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)